|
Date:
January 17, 2007
UCLA
and NYU Microbiologists Decipher the Genome of the Parasite That
Causes the Sexually Transmitted Disease Trichomoniasis
Trichomonas vaginalis
Trichomanas vaginalis, cells
causing a vaginal inflammation (trichomoniasis) that results
in a persistent discharge and itching. Magnification 600X.
|
Scientists at UCLA and NYU
have deciphered the genome of the parasite causing
trichomoniasis, and their research may lead to new approaches to
improve the diagnosis and treatment of this common sexually
transmitted disease.
Trichomoniasis affects an
estimated 170 million people a year, with more than 5 million
cases reported in North America. This global health problem
results when the single-celled parasite Trichomonas vaginalis
sets up house in the reproductive tract.
Led by Patricia Johnson, a UCLA
professor of microbiology in the department of microbiology,
immunology and molecular genetics, and Jane Carlton, an associate
professor in the department of medical parasitology at New York
University School of Medicine, the team of scientists took four
years to crack the surprisingly large genome of this parasite.
They published the draft sequence of the parasite's genome in the
Jan. 12 issue of the journal Science.
"Patricia Johnson cloned
the first Trichomonas vaginalis gene in 1990 as an
assistant professor at UCLA, and it is tremendously gratifying
that she is now senior author on a landmark publication
describing the entire genome," said Jeffery F. Miller, chair
of microbiology, immunology and molecular genetics at UCLA and
UCLA's M. Philip Davis Professor of Microbiology and
Immunology. "The implications of this work range from
fundamental insights into early evolution to understanding
pathogenesis and developing drugs and vaccines. This is a
major accomplishment in the field."
"T. vaginalis is an
extremely successful parasite, capable of establishing and
maintaining infections in both men and women," Johnson said.
"Symptoms vary greatly among infected individuals, and the
reason for this wide range of variable pathogenic outcomes is
poorly understood. Among the many new insights brought by
deciphering the genome sequence of this organism are ones that
provide new clues for identifying critical factors that are
responsible for pathogenesis."
In women, the parasite binds to
the vaginal lining and is capable of destroying vaginal
epithelial cells, which make up the surface of this tissue,
Johnson said. This results in vaginitis, with irritation of local
tissues. Erosion of cervical tissues may occur, and complications
can result in sterility. A big threat from infection also occurs
in pregnant women, who are at risk for ruptured membranes,
preterm deliveries and low-birth-weight babies. In men, the
parasite is a cause of nongonococcal urethritis, but infection is
generally asymptomatic and self-limiting.
In both men and women,
trichomoniasis is known to increase susceptibility to HIV, the
virus that causes AIDS. "In countries where AIDS runs
rampant, such as South Africa, the incidence of trichomoniasis is
also extraordinarily high, and trichomoniasis is thought to have
significantly contributed to the spread of HIV," Johnson
said.
To survive, T. vaginalis
must adapt to multiple microenvironments and changes in the
reproductive tract. A critical property of infection is the
parasite's ability to adhere to human cells and to kill
neighboring cells.
"The sequence of its
genome now reveals a number of factors, including putative
adhesion proteins and secreted factors that may result in killing
of human cells," Johnson said. "Should future studies
confirm a critical role for these, they could provide important
therapeutic targets."
Currently, only one class of
drugs — nitroimidazoles — is licensed for treatment
of trichomoniasis in the United States, and the emergence of
parasite strains that are resistant to these drugs is on the
rise. There is a clear need to develop additional effective
drugs, Johnson said.
The T. vaginalis genome
project began in 2002 and was funded by the National Institute of
Allergy and Infectious Diseases, part of the National Institutes
of Health. The first draft sequence was available in 2003, but it
took years of additional work by 66 scientists in 10 countries,
with expertise in cell biology, biochemistry and bioinformatics,
to complete the work reported this week in Science.
In addition to providing
putative pathogenic and therapeutic targets, the genome could
help with diagnostics too. "This genome contains a large
number of repeat sequences, which could be used to devise a
diagnostic test that would specifically identify this pathogen,"
said researcher Jane Carlton from New York University.
The parasite's large genome has
nearly 26,000 confirmed genes, which is on par with the human
genome. There may be an additional 34,000 unconfirmed genes,
bringing the total gene count to about 60,000.
"T. vaginalis has
one of the highest gene counts of any organism in the microbe,
animal or plant community, probably because of the puzzlingly
high number of genes repeated in the genome," Carlton said.
The scientists say they still
plan to work on a final gene count. "The genome was much,
much bigger than we had expected, actually 10 times what we had
expected," Carlton said. All other previously sequenced
parasites had much smaller genomes.
T. vaginalis is
typically a pear-shaped organism, but when it sticks to the
vaginal wall, the parasite flattens and dramatically increases
its surface area. The scientists hypothesize that this trait
brought the microbe a selective advantage during its evolution: A
parasite with a big surface area, enabled by a big genome, is
better at colonizing the area it is infecting. The organism also
shows predatory behavior. It "eats up" good bacteria in
the vagina using a process called phagocytosis. This makes the
vagina more alkaline and more hospitable toward Trichomonas
and other pathogens.
This little bug presented a
sizable genomics challenge.
"The big issue is that we
don't really have the capability of dealing with a genome like
Trichomonas," Carlton said. The sequencing technology
and the computer algorithms typically used to assemble and align
sequenced gene fragments with computers are not available to deal
with this parasite. The cause of the headache for researchers:
the repeats in the genome.
To sequence a genome, it is
broken down into "reads," which are snippets of DNA
with 600 units, or bases. Computer programs then identify similar
reads — the ones with overlapping fragments of the same
sequence. These fragments are then collapsed into contiguous
sequences, or "contigs," so the genome is put back
together like a jigsaw puzzle.
Because Trichomonas has
many repeating sequences, the computer algorithm got completely
stuck. It could not assemble the contigs. The scientists were
stumped. Only after bioinformatics experts and software
engineers, including colleagues Steven Salzberg, Arthur Delcher
and Michael Schatz from the University of Maryland, reworked the
algorithm to tackle the informatics challenge could the genome
project proceed to the draft now published.
"This project provides a
good example of the most productive way to approach scientific
research that relies on cutting-edge, advanced technologies, as
so many projects do these days," Johnson said. "A
coordinated, synergistic team effort involving many dedicated
scientists with different expertises and perspectives and a
strong drive to succeed — that's what it takes."
Source
/ Credit: University California Los Angeles
|